Mapping and predicting mortality from systemic sclerosisMuriel Elhaï, Carlos Alberto von Mühlen, É. Hachulla et al.|Annals of the Rheumatic Diseases|2017Cited by 699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Jörg H. W. Distler et al.|Annals of the Rheumatic Diseases|2014Cited by 432
Human genital tracts microbiota: dysbiosis crucial for infertilityMary Anna Venneri, Andrea Lenzi, Edoardo Franceschini et al.|Journal of Endocrinological Investigation|2022Cited by 74
Does the Impact of <scp>COVID</scp>‐19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Fabian A. Mendoza, Patrícia Carreira et al.|Arthritis Care & Research|2023Cited by 2